The Pharma is pretty flat in the last 7 days, but Eli Lilly has stood out, gaining 3.3%. The past year has been better, since the industry has gained 17% in that time. As for the next few years, earnings are expected to grow by 28% per annum.
Has the U.S. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sat, 15 Jun 2024 | US$1.9t | US$358.3b | US$14.1b | 15.3x | 137.9x | 5.4x |
Mon, 13 May 2024 | US$1.9t | US$358.2b | US$13.7b | 17.9x | 135x | 5.2x |
Wed, 10 Apr 2024 | US$1.9t | US$355.1b | US$23.9b | 25x | 77.8x | 5.2x |
Fri, 08 Mar 2024 | US$1.9t | US$357.3b | US$20.0b | 22.9x | 94.6x | 5.3x |
Sun, 04 Feb 2024 | US$1.8t | US$353.1b | US$22.0b | 31.7x | 81.4x | 5.1x |
Tue, 02 Jan 2024 | US$1.7t | US$375.2b | US$33.8b | 31.9x | 49.9x | 4.5x |
Thu, 30 Nov 2023 | US$1.6t | US$375.1b | US$33.9b | 26.2x | 48.1x | 4.4x |
Sat, 28 Oct 2023 | US$1.6t | US$383.5b | US$46.6b | 14.2x | 34.1x | 4.1x |
Mon, 25 Sep 2023 | US$1.7t | US$381.8b | US$43.9b | 19.9x | 38.3x | 4.4x |
Wed, 23 Aug 2023 | US$1.8t | US$381.6b | US$44.1b | 20.2x | 40.1x | 4.6x |
Fri, 21 Jul 2023 | US$1.7t | US$394.3b | US$60.5b | 18.3x | 28.3x | 4.3x |
Sun, 18 Jun 2023 | US$1.7t | US$392.8b | US$60.1b | 19x | 29x | 4.4x |
Tue, 16 May 2023 | US$1.7t | US$393.1b | US$60.4b | 20.4x | 28.7x | 4.4x |
Thu, 13 Apr 2023 | US$1.7t | US$401.3b | US$68.5b | 17x | 24.2x | 4.1x |
Sat, 11 Mar 2023 | US$1.5t | US$401.1b | US$69.6b | 17.4x | 21.9x | 3.8x |
Mon, 06 Feb 2023 | US$1.7t | US$402.0b | US$69.9b | 18.2x | 23.7x | 4.1x |
Wed, 04 Jan 2023 | US$1.8t | US$403.7b | US$70.7b | 17.1x | 24.8x | 4.3x |
Fri, 02 Dec 2022 | US$1.8t | US$403.7b | US$70.7b | 17.1x | 25.2x | 4.4x |
Sun, 30 Oct 2022 | US$1.7t | US$404.8b | US$70.8b | 16.1x | 24.1x | 4.2x |
Tue, 27 Sep 2022 | US$1.5t | US$403.0b | US$71.3b | 12.7x | 21.7x | 3.8x |
Thu, 25 Aug 2022 | US$1.6t | US$402.8b | US$70.2b | 14.2x | 23.2x | 4x |
Sat, 23 Jul 2022 | US$1.7t | US$393.1b | US$63.6b | 21.7x | 26.1x | 4.2x |
Mon, 20 Jun 2022 | US$1.6t | US$392.5b | US$64.7b | 20.4x | 24.2x | 4x |
Wed, 18 May 2022 | US$1.7t | US$392.5b | US$64.5b | 21.1x | 25.6x | 4.2x |
Fri, 15 Apr 2022 | US$1.7t | US$373.7b | US$60.9b | 22.7x | 27.8x | 4.5x |
Sun, 13 Mar 2022 | US$1.6t | US$373.8b | US$60.3b | 19.5x | 26.1x | 4.2x |
Tue, 08 Feb 2022 | US$1.6t | US$365.5b | US$53.0b | 21x | 29.8x | 4.3x |
Thu, 06 Jan 2022 | US$1.6t | US$361.1b | US$37.8b | 23.6x | 42.9x | 4.5x |
Sat, 04 Dec 2021 | US$1.5t | US$361.1b | US$38.1b | 22.7x | 40.4x | 4.3x |
Mon, 01 Nov 2021 | US$1.6t | US$344.2b | US$31.3b | 20.6x | 49.8x | 4.5x |
Wed, 29 Sep 2021 | US$1.5t | US$337.6b | US$25.8b | 21.7x | 57.3x | 4.4x |
Fri, 27 Aug 2021 | US$1.6t | US$338.5b | US$25.8b | 21.2x | 61.1x | 4.7x |
Sat, 03 Jul 2021 | US$1.5t | US$324.4b | US$20.4b | 23.4x | 73.2x | 4.6x |
73.2x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 1.21% | |
Healthcare | -0.42% | |
Pharma | 0.43% | |
Pharma | 0.43% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
LLY Eli Lilly | US$878.45 | 3.3% +US$25.6b | 96.2% | PE128.9x | |
TEVA Teva Pharmaceutical Industries | US$17.16 | 2.0% +US$385.1m | 127.6% | PS1.2x | |
VRNA Verona Pharma | US$15.14 | 24.8% +US$244.1m | -28.7% | PB5.5x | |
PHVS Pharvaris | US$18.76 | 19.7% +US$166.3m | 61.4% | PB2.6x | |
OCUL Ocular Therapeutix | US$5.75 | 16.4% +US$125.5m | 19.5% | PS14.9x |